AU2002210767A1 - Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis - Google Patents

Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis

Info

Publication number
AU2002210767A1
AU2002210767A1 AU2002210767A AU1076702A AU2002210767A1 AU 2002210767 A1 AU2002210767 A1 AU 2002210767A1 AU 2002210767 A AU2002210767 A AU 2002210767A AU 1076702 A AU1076702 A AU 1076702A AU 2002210767 A1 AU2002210767 A1 AU 2002210767A1
Authority
AU
Australia
Prior art keywords
pla2
atherosclerosis
susceptibility
kit
polymorphic variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210767A
Inventor
David Campbell
Ralph Mcginnins
Nigel Spurr
Ana Maria Valdes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2002210767A1 publication Critical patent/AU2002210767A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002210767A 2000-11-04 2001-11-02 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis Abandoned AU2002210767A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0027181.7 2000-11-04
GBGB0027181.7A GB0027181D0 (en) 2000-11-04 2000-11-04 New use
PCT/GB2001/004876 WO2002036817A2 (en) 2000-11-04 2001-11-02 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis

Publications (1)

Publication Number Publication Date
AU2002210767A1 true AU2002210767A1 (en) 2002-05-15

Family

ID=9902708

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210767A Abandoned AU2002210767A1 (en) 2000-11-04 2001-11-02 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis

Country Status (6)

Country Link
US (1) US20040259087A1 (en)
EP (1) EP1330545A2 (en)
JP (1) JP2004512841A (en)
AU (1) AU2002210767A1 (en)
GB (1) GB0027181D0 (en)
WO (1) WO2002036817A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69423436T2 (en) 1993-06-25 2000-09-07 Smithkline Beecham P.L.C., Brentford PHOSPHOLIPASE A2 TIED TO LIPOPROTEIN, INHIBITORS THEREOF AND THEIR USE FOR DIAGNOSIS AND THERAPY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622832A (en) * 1990-02-28 1997-04-22 Genetics Institute, Inc. Arachidonic acid releasing phospholipase A2 enzyme and methods of use
DE69423436T2 (en) * 1993-06-25 2000-09-07 Smithkline Beecham P.L.C., Brentford PHOSPHOLIPASE A2 TIED TO LIPOPROTEIN, INHIBITORS THEREOF AND THEIR USE FOR DIAGNOSIS AND THERAPY
ATE201905T1 (en) * 1993-10-06 2001-06-15 Icos Corp PLATELE ACTIVATE FACTOR ACETHYL HYDROLASE
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Also Published As

Publication number Publication date
JP2004512841A (en) 2004-04-30
US20040259087A1 (en) 2004-12-23
WO2002036817A3 (en) 2002-09-06
GB0027181D0 (en) 2000-12-27
EP1330545A2 (en) 2003-07-30
WO2002036817A2 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
GB0121314D0 (en) β-Secretase enzyme compositions and methods
AU6214800A (en) Exercise kit and method of using same
AU2001252973A1 (en) Biosensor and related method
AU2830200A (en) Electrophoresis display and its production method
AU4523801A (en) Computerized visual behavior analysis and training method
SI1185536T1 (en) Hemisynthetic method and intermediates thereof
AU1939801A (en) In situ bioreactors and methods of use thereof
AU4903701A (en) Method and apparatus for assessing susceptibility to stroke
AU2745000A (en) Method for nucleic acid isolation and kit
AU2001237566A1 (en) Improvements in and relating to investigating corrosion
IL149676A0 (en) Methods and kits for determining nucleotide variations
AU2001233837A1 (en) Benzthiazoles as tnf and pde-iv inhibitors
GB0020808D0 (en) Scratch resisteance testing apparatrus and method
AU2002218417A1 (en) Nucleic acid extraction method and kit
AU2002210767A1 (en) Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis
AU2001285172A1 (en) Enhanced electro-deposition device and method
GB0013444D0 (en) Test method and kit
AU2001240814A1 (en) Improvements in and relating to investigating corrosion
AU2001292468A1 (en) Methods and means of rna analysis
GB0014643D0 (en) Methods and assemblies
AU2001280198A1 (en) Airway-specific trypsin-like enzymes and method of using the same
EP1031954A3 (en) Measuring arrangement and method
AU7437300A (en) Method to determine the susceptibility of scrapie in sheep
AU2001296244A1 (en) Method of minimizing environmental effect in aluminides
AU2000280285A1 (en) Oxygenase enzymes and screening method